Amicus Therapeutics, Inc.

BMV:FOLD * Rapport sur les actions

Capitalisation boursière : Mex$58.4b

Amicus Therapeutics Gestion

Gestion contrôle des critères 2/4

Amicus Therapeutics' CEO is Brad Campbell, appointed in Jan 2015, has a tenure of 8.25 years. total yearly compensation is $4.91M, comprised of 11.2% salary and 88.8% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth MX$84.57M. The average tenure of the management team and the board of directors is 6.1 years and 5.8 years respectively.

Informations clés

Brad Campbell

Directeur général

US$4.9m

Rémunération totale

Pourcentage du salaire du PDG11.2%
Durée du mandat du directeur général8.3yrs
Propriété du PDG0.1%
Durée moyenne d'occupation des postes de direction6.1yrs
Durée moyenne du mandat des membres du conseil d'administration5.8yrs

Mises à jour récentes de la gestion

Recent updates

Analyse de la rémunération des PDG

Comment la rémunération de Brad Campbell a-t-elle évolué par rapport aux bénéfices de Amicus Therapeutics?
DateRémunération totaleSalaireBénéfices de l'entreprise
Dec 31 2022n/an/a

-US$237m

Sep 30 2022n/an/a

-US$264m

Jun 30 2022n/an/a

-US$281m

Mar 31 2022n/an/a

-US$270m

Dec 31 2021US$5mUS$551k

-US$250m

Sep 30 2021n/an/a

-US$239m

Jun 30 2021n/an/a

-US$252m

Mar 31 2021n/an/a

-US$254m

Dec 31 2020US$5mUS$516k

-US$277m

Sep 30 2020n/an/a

-US$295m

Jun 30 2020n/an/a

-US$293m

Mar 31 2020n/an/a

-US$325m

Dec 31 2019US$4mUS$501k

-US$356m

Sep 30 2019n/an/a

-US$345m

Jun 30 2019n/an/a

-US$442m

Mar 31 2019n/an/a

-US$419m

Dec 31 2018US$3mUS$468k

-US$349m

Sep 30 2018n/an/a

-US$340m

Jun 30 2018n/an/a

-US$293m

Mar 31 2018n/an/a

-US$279m

Dec 31 2017US$2mUS$450k

-US$284m

Sep 30 2017n/an/a

-US$273m

Jun 30 2017n/an/a

-US$208m

Mar 31 2017n/an/a

-US$211m

Dec 31 2016US$2mUS$427k

-US$200m

Rémunération vs marché: Brad's total compensation ($USD4.91M) is above average for companies of similar size in the MX market ($USD1.61M).

Rémunération et revenus: Brad's compensation has increased whilst the company is unprofitable.


PDG

Brad Campbell (46 yo)

8.3yrs

Titularisation

US$4,911,455

Compensation

Mr. Bradley L. Campbell, also known as Brad, MBA, serves as Director of Gennao Bio, Inc. since March 2022. He serves as Director of Alliance for Regenerative Medicine. He served as Chief Operating Officer...


Équipe de direction

NomPositionTitularisationCompensationPropriété
John Crowley
Executive Chairman18.7yrsUS$9.99m0.37%
MX$ 214.1m
Bradley Campbell
CEO, President & Director8.3yrsUS$4.91m0.14%
MX$ 84.6m
Daphne Quimi
Chief Financial Officer4.3yrsUS$3.06m0.088%
MX$ 51.5m
Ellen Rosenberg
Chief Legal Officer & Corporate Secretary7.2yrsUS$3.05m0.049%
MX$ 28.7m
David Clark
Chief People Officer4.5yrsUS$2.62m0.039%
MX$ 22.5m
Samantha Prout
VP, Global Controller & Principal Accounting Officer5.1yrspas de données0.029%
MX$ 17.1m
Jill Weimer
Chief Science Officerno datapas de donnéespas de données
Andrew Faughnan
Senior Director of Investor Relationsno datapas de donnéespas de données
Patrik Florencio
Global Chief Compliance & Risk Officer7.7yrspas de donnéespas de données
Diana Moore
Head of Global Corporate Communicationsno datapas de donnéespas de données
Jayne Gershkowitz
Chief Patient Advocate7.6yrspas de donnéespas de données
Jeffrey Castelli
Chief Development Officerno datapas de données0.078%
MX$ 45.5m

6.1yrs

Durée moyenne de l'emploi

52.5yo

Âge moyen

Gestion expérimentée: FOLD *'s management team is seasoned and experienced (6.1 years average tenure).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
John Crowley
Executive Chairman18.7yrsUS$9.99m0.37%
MX$ 214.1m
Bradley Campbell
CEO, President & Director4.8yrsUS$4.91m0.14%
MX$ 84.6m
Burke Whitman
Independent Director3.8yrsUS$390.00k0.022%
MX$ 13.0m
Michael Kelly
Independent Director2.3yrsUS$390.00k0.0051%
MX$ 3.0m
Glenn Sblendorio
Independent Director16.8yrsUS$402.50k0.016%
MX$ 9.5m
Margaret McGlynn
Independent Director13.5yrsUS$400.00k0.0056%
MX$ 3.3m
Craig Wheeler
Independent Director6.8yrsUS$394.99k0.011%
MX$ 6.4m
Michael Raab
Lead Independent Director19.3yrsUS$428.28k0.017%
MX$ 9.8m
Eiry Roberts
Independent Director1.8yrsUS$522.36k0.0020%
MX$ 1.2m
Lynn Bleil
Independent Director4.6yrsUS$395.00k0.013%
MX$ 7.9m

5.8yrs

Durée moyenne de l'emploi

60.5yo

Âge moyen

Conseil d'administration expérimenté: FOLD *'s board of directors are considered experienced (5.8 years average tenure).